Voters in California will decide next month on an initiative that would assign $3 billion to research on human embryonic stem cells. But the proposal is less of an unalloyed blessing than it seems.
The Russian Academy of Sciences is failing to provide either the quality of research or the scientific advice that reformers had been hoping for.